Literature DB >> 20060208

Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture.

Zhihua An1, Christian B Gluck, Megan L Choy, Laura J Kaufman.   

Abstract

High grade gliomas are aggressive cancers that are not well addressed by current chemotherapies, in large measure because these drugs do not curtail the diffuse invasion of glioma cells into brain tissue surrounding the tumor. Here, we investigate the effects of suberoylanilide hydroxamic acid (SAHA) on glioma cells in 2D and 3D in vitro assays, as SAHA has previously been shown to significantly increase apoptosis, decrease proliferation, and interfere with migration in other cell lines. We find that SAHA has significant independent effects on proliferation, migration, and invasion. These effects are seen in both 2D and 3D culture. In 3D culture, with glioma spheroids embedded in collagen I matrices, SAHA independently limits both glioma invasion and the reorganization of the tumor surroundings that usually proceeds such invasion. The decreased matrix reorganization and invasion is not accompanied by decreased production or activity of matrix-metalloproteases but instead may be related to increased cell-cell adhesion. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060208     DOI: 10.1016/j.canlet.2009.12.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.

Authors:  Andrew R Tsen; Patrick M Long; Heather E Driscoll; Matthew T Davies; Benjamin A Teasdale; Paul L Penar; William W Pendlebury; Jeffrey L Spees; Sean E Lawler; Mariano S Viapiano; Diane M Jaworski
Journal:  Int J Cancer       Date:  2013-09-30       Impact factor: 7.396

2.  Influence of chondroitin sulfate and hyaluronic acid on structure, mechanical properties, and glioma invasion of collagen I gels.

Authors:  Ya-li Yang; Charles Sun; Matthew E Wilhelm; Laura J Fox; Jieling Zhu; Laura J Kaufman
Journal:  Biomaterials       Date:  2011-08-05       Impact factor: 12.479

3.  Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.

Authors:  Shan Lu; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2012-11-30       Impact factor: 4.617

Review 4.  Targeting of histone deacetylases in brain tumors.

Authors:  Jonas Ecker; Olaf Witt; Till Milde
Journal:  CNS Oncol       Date:  2013-07

5.  Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

Authors:  Eudocia Q Lee; Vinay K Puduvalli; Joel M Reid; John G Kuhn; Kathleen R Lamborn; Timothy F Cloughesy; Susan M Chang; Jan Drappatz; W K Alfred Yung; Mark R Gilbert; H Ian Robins; Frank S Lieberman; Andrew B Lassman; Renee M McGovern; Jihong Xu; Serena Desideri; Xiabu Ye; Matthew M Ames; Igor Espinoza-Delgado; Michael D Prados; Patrick Y Wen
Journal:  Clin Cancer Res       Date:  2012-08-24       Impact factor: 12.531

Review 6.  Deregulated chromatin remodeling in the pathobiology of brain tumors.

Authors:  Anastasia Spyropoulou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2013-03       Impact factor: 3.843

7.  Three-dimensional patterning of multiple cell populations through orthogonal genetic control of cell motility.

Authors:  Joanna L MacKay; Anshum Sood; Sanjay Kumar
Journal:  Soft Matter       Date:  2014-04-14       Impact factor: 3.679

Review 8.  Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience.

Authors:  Pavel Bezecny
Journal:  Med Oncol       Date:  2014-05-18       Impact factor: 3.064

9.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

Review 10.  Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma.

Authors:  Chaitanya Tondepu; Lohitash Karumbaiah
Journal:  Adv Healthc Mater       Date:  2021-12-29       Impact factor: 11.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.